TCM
VIVS

Trent Capital Management’s VivoSim Labs VIVS Stock Holding History

Trent Capital Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$222K Buy
+352
New +$237K 0.33% 27
2016
Q4 		$293K Buy
+360
New +$286K 0.33% 31

Other funds holding VIVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Trent Capital Management's VIVS Position: Q2 2017 in Review

Trent Capital Management opened a new position in VivoSim Labs (VIVS) in Q2 2017: 352 shares worth $222K. The stake represents 0.33% of the portfolio and ranks #27 among its holdings. This is a return to the name: Trent Capital Management previously reported a position in VIVS as recently as Q4 2016.

Trent Capital Management first reported a position in VIVS in Q4 2016 and has held it in 2 quarters since. The position peaked at $293K in Q4 2016. 117 funds tracked by Wall St. Rank hold VIVS as of Q2 2017.

  • Trent Capital Management held 352 shares of VivoSim Labs worth $222K as of Q2 2017.
  • VivoSim Labs was a new Trent Capital Management position in Q2 2017.
  • VivoSim Labs made up 0.33% of Trent Capital Management's portfolio in Q2 2017, its #27 holding.
  • Trent Capital Management first reported a position in VivoSim Labs in Q4 2016 and has held it in 2 quarters since.
  • Trent Capital Management's VivoSim Labs position peaked at $293K in Q4 2016.
  • 117 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2017.

Based on Trent Capital Management's 13F filing for Q2 2017, filed 1 Aug 2017.